Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT for Steroid Resistant/Dependent Acute GI GVHD
NCT03812705Phase 2Completed
- Sponsor
- Shanghai General Hospital
- Start
- Dec 2018
- Primary completion
- Mar 2024
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of fecal microbiome transplant in graft-versus-host disease (GVHD), sponsored by Shanghai General Hospital. Started Dec 2018; status: completed.
02
Drugs
fecal microbiome transplant
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT03812705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03812705.